Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation.
about
Making the cut: Innovative methods for optimizing perfusion-based migration assays.Novel protein kinase targets in vascular smooth muscle therapeutics.Engineering Cardiovascular Implant Surfaces to Create a Vascular Endothelial Growth Microenvironment.Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth.
P2860
Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Soluble guanylyl cyclase-activ ...... SP-serine 239 phosphorylation.
@en
type
label
Soluble guanylyl cyclase-activ ...... SP-serine 239 phosphorylation.
@en
prefLabel
Soluble guanylyl cyclase-activ ...... SP-serine 239 phosphorylation.
@en
P2093
P2860
P1433
P1476
Soluble guanylyl cyclase-activ ...... SP-serine 239 phosphorylation.
@en
P2093
Andrew W Holt
Brian M Shewchuk
Chintamani N Joshi
Danielle N Martin
David A Tulis
Jake T Francisco
Joshua D Stone
Patti R Shaver
Robert M Lust
Shaquria P Adderley
P2860
P304
P356
10.1016/J.CELLSIG.2016.06.012
P577
2016-06-11T00:00:00Z